| License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-416783
- DOI to cite this document:
- 10.5283/epub.41678
This publication is part of the DEAL contract with Wiley.
Abstract
Multivalent nanoparticle binding to cells can be of picomolar avidity making such interactions almost as intense as those seen with antibodies. However, reducing nanoparticle design exclusively to avidity optimization by the choice of ligand and its surface density does not sufficiently account for controlling and understanding cell-particle interactions. Cell uptake, for example, is of paramount ...
Owner only: item control page
Download Statistics